Digestive System Inflammatory Bowel Disease

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Inflammatory Bowel Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Inflammatory Bowel Disease Projects
--4SC AG
--Ajinomoto Co., Inc.
--Archimedes Pharma Limited
--AstraZeneca Plc
--Biocon Ltd
--Chelsea Therapeutics International Ltd
--Dong-A Pharmaceutical Co., Ltd.
--Giuliani S.p.A
--GW Pharmaceuticals PLC
--Merckle Group
--Pipex Pharmaceuticals, Inc.

--Top Companies in early stage Inflammatory Bowel Disease Projects
--Advitech inc.
--Ablynx nv
--AnGes MG, Inc.
--Alba Therapeutics Corporation
--Aphoenix, Inc.
--Antibe Therapeutics Inc.
--Genentech Inc
--FivePrime Therapeutics, Inc.
--Hunter-Fleming Ltd
--Genpat77 Pharmacogenetics AG
--Johnson & Johnson
--Inflabloc Pharmaceuticals, Inc.
--erly Pharmadigm, Inc)
--Rimonyx Pharmaceuticals Ltd.
--Pharmos Corporation
--Samyang Corporation
--Rottapharm SpA
--Symbigene
--Solvay S.A.
--Welichem Biotech Inc.
--Viron Therapeutics Inc

Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View